The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Matsuzaki, Junko
Item TypeName
Concept Antigens, Neoplasm
Concept Antigens, Ly
Concept Histocompatibility Antigens Class II
Concept HLA-A Antigens
Concept CD28 Antigens
Concept Histocompatibility Antigens Class I
Concept Antigens, Differentiation, Myelomonocytic
Concept Antigens, CD
Concept Minor Histocompatibility Antigens
Concept Leukocyte Common Antigens
Academic Article Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
Academic Article Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.
Academic Article Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
Academic Article Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.
Academic Article A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.
Academic Article LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.
Academic Article Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.
Academic Article Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
Academic Article HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer.
Academic Article Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
Academic Article Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.
Academic Article Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
Academic Article Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.
Academic Article Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells.
Academic Article NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.
Academic Article Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
Academic Article Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
Academic Article Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
Academic Article Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.
Academic Article Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.
Academic Article Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo.
Academic Article NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer.
Academic Article Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Academic Article Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Academic Article Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Search Criteria
  • Hepatitis B e Antigens